Actively Recruiting

Phase Not Applicable
Age: 19Years +
All Genders
NCT05898581

PENG Block vs. Intraoperative Local Anesthetic Infiltration for Total Hip Arthroplasty

Led by London Health Sciences Centre Research Institute OR Lawson Research Institute of St. Joseph's · Updated on 2025-09-18

60

Participants Needed

1

Research Sites

86 weeks

Total Duration

On this page

AI-Summary

What this Trial Is About

Currently, the analgesic standard of care for patients undergoing total hip arthroplasty (THA) at our centre is intraoperative infiltration with a solution of local anesthetic, morphine (opioid), and ketorolac (nonsteroidal anti-inflammatory drug - NSAID). If a patient has a contraindication for the use of an opioid or NSAIDs, this infiltration is performed with a plain local anesthetic. No blocks (numbing of certain nerves to prevent pain from occurring in that area) are performed for postoperative pain in these patients. The pericapsular nerve group (PENG) block is a recently described technique with limited data in the literature that has assessed the benefits of using this nerve block for THA procedures. The purpose of this study is to investigate if the ultrasound-guided PENG block can provide non-inferior postoperative analgesia compared to local intraoperative anesthetic infiltration (ILAI) with an associated cost benefit for patients undergoing THA.

CONDITIONS

Official Title

PENG Block vs. Intraoperative Local Anesthetic Infiltration for Total Hip Arthroplasty

Who Can Participate

Age: 19Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adult patient (>18 years old)
  • Undergoing total hip arthroplasty with a direct lateral surgical approach (transgluteal approach)
  • Able to provide verbal or written consent to participate in this trial
Not Eligible

You will not qualify if you...

  • Contraindication for spinal anesthesia
  • Contraindication for regional analgesia
  • Undergoing total hip arthroplasty with a direct anterior surgical approach
  • Undergoing total hip arthroplasty for hip revision
  • Undergoing total hip arthroplasty under One Day Stay (ODS) admission
  • Received opioids intrathecally
  • Residual motor block six hours after completion of spinal anesthesia
  • History of regular opioid use for more than three months
  • Unable to perform knee extension on the operated side
  • Pregnancy

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

London Health Sciences Centre

London, Ontario, Canada

Actively Recruiting

Loading map...

Research Team

S

Shalini Dhir, FRCPC

CONTACT

R

Rodrigo Araujo Monteiro da Silva, MD

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

DOUBLE

Allocation

RANDOMIZED

Model

PARALLEL

Primary Purpose

TREATMENT

Number of Arms

2

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here